Andere Sprachen Uni-Bio Science Group Limited

Aktien

A0YA20

KYG9198H1406

690

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:09:00 03.05.2024			% 5 Tage	% 1. Jan.
0,084 ^HKD	-1,18 %		-1,18 %	+16,67 %

27.03.	Uni-Bio Science Group Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI
14.02.	Uni-Bio Science's Gewinn soll 2023 ansteigen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
Uni-Bio Science's Profit to Climb in 2023	14.02.
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	14.02.
Chinese Regulator NMPA Accepts Uni-Bio's Marketing Application for Eye Drops	23.01.
Uni-Bio Science Group Limited Announces the Acceptance of its Marketing Application for Diquafosol Sodium Eye Drops by the China National Medical Products Administration	23.01.
China Grants Uni-Bio Science's Injection for Orthopedic Diseases	22.01.
Uni-Bio Science Group Limited Announces Approval of Marketing Application of Bogutai (Teriparatide Injection) by the China National Medical Products Administration	22.01.
Uni-Bio Science Group Limited commences an Equity Buyback for 636,476,815 shares, representing 10% of its issued share capital, under the authorization approved on May 19, 2023.	13.12.
Uni-Bio Science Group Limited Announces the Resignation of Ms. Zhang Yanfen as Executive Director	15.11.
Uni-Bio Science's Unit Grants 7.2 Million Yuan Loan to Taili Biomedical Technology	18.09.23
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	28.08.23
Uni-Bio Science Group Limited Appoints Zhang Yanfen as an Executive Director	11.08.23
Uni Bio Science : Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships	28.03.23
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27.03.23
Uni-Bio Science Group Limited Provides Financial Guidance for the Year Ended 31 December 2022	06.03.23
Uni-Bio Science Unit Renews Property Lease for Two Years	23.12.22
Uni Bio Science : Interim Report 2022	12.09.22
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	29.08.22
Uni-Bio Science Group Limited Announces Marketing Application of Bogutai (Teriparatide Injection) Officially Accepted by the China National Medical Products Administration	29.06.22
Uni Bio Science : opens Hong Kong research centre,Future R&D focus in four major businesses	13.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Uni-Bio Science Group Limited

Aktien

A0YA20

KYG9198H1406

690

Andere Sprachen

Filter